beIN SPORTS will air a new six-part documentary this August, A Glória Eterna, following Flamengo’s road to victory at the 2019 CONMEBOL Libertadores.
The series features exclusive behind the scenes footage and will be broadcast in 5 languages across beIN’s international network in 43 countries and 5 continents, including the Middle East & North Africa (MENA), Asia Pacific, France, Turkey, and North America.
A Glória Eterna, a creation of FC DIEZ MEDIA, CONMEBOL’s exclusive adviser on their commercial and audiovisual rights for all of the Confederation’s club competitions, details Flamengo’s 38-year wait to become CONMEBOL Libertadores champions once again.
The journey tracks the prior 13 unsuccessful attempts before culminating in 2019’s dramatic final with interviews from the players, ex-players, and the managers of Flamengo and River Plate both before and after the 2019 Single Final in Lima.
“After one of the greatest comebacks in football history, A Glória Eterna will be a real draw for football fans everywhere. In recent years we’ve seen sports fans captivated by behind-the-scenes docu-series, so beIN is thrilled to offer this new series to our millions of global viewers, who will be exposed to the passion, history, and excitement of South American football like never before,” said Antonio Briceño, Deputy Managing Director for beIN SPORTS North America.
“The great show offered by Flamengo throughout the tournament, together with the fast-paced Single Final in Lima, deserved to be told with all the details. A Glória Eterna captures the passion for football in South America and a story of overcoming with the CONMEBOL Libertadores as a great goal”, said Juan Emilio Roa, Commercial Director of CONMEBOL.
beIN SPORTS exclusively broadcasts the Copa CONMEBOL Libertadores football tournament across the USA, Canada, Australia, New Zealand, and 24 territories in the Middle East and North Africa until 2022. The 2020 tournament will resume on 15th September, following the temporary suspension of the live sport due to COVID-19.